The UK’s Medicines and Healthcare products Regulatory Agency has officially transitioned its human medicine export certificate system to a fully electronic platform, eliminating paper-based processes entirely. This modernisation initiative represents a significant advancement in pharmaceutical regulatory compliance and administrative efficiency for UK-based manufacturers and distributors.
The new digital system provides 24/7 access to certificate applications and real-time status updates, enabling companies to monitor their export documentation throughout the approval process. By streamlining workflows and reducing processing delays, the MHRA’s platform maintains rigorous safety and quality standards while improving operational efficiency across the pharmaceutical export sector.
This digitisation aligns with broader European health policy trends toward electronic regulatory systems, positioning the UK pharmaceutical industry for enhanced international competitiveness. Read the full article on GMJ Newsroom.
Was this article helpful?
GMJ Brief · Announcement
📰 Read the full article: UK Launches Digital Export Certificate System for Human Medicines →
